Search Results - Marsicovetere, G

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    42 Effects of ivacaftor in an adult patient with cystic fibrosis who carries the 3272-26A → G mutation, resulting in residual functioning protein, and has severe lung disease

    42 Effects of ivacaftor in an adult patient with cystic fibrosis who carries the 3272-26A → G mutation, resulting in residual functioning protein, and has severe lung disease by Salvatore, D, Colangelo, C, D'Andria, M, Marsicovetere, G, Passarella, D

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    WS12.3 Effectiveness and safety of elexacaftor/tezacaftor/ivacaftor in cystic fibrosis severe patients with the F508del/minimal function genotype

    WS12.3 Effectiveness and safety of elexacaftor/tezacaftor/ivacaftor in cystic fibrosis severe patients with the F508del/minimal function genotype by Carnovale, V., Iacotucci, P., Terlizzi, V., Colangelo, C., Medio, P., Ferrillo, L., De Gregorio, F., Francalanci, M., Taccetti, G., Buonaurio, S., d'Ippolito, M., Marsicovetere, G., D'Andria, M., Ferrara, N., Salvatore, D.

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    P037 Elexacaftor/tezacaftor/ivacaftor improve lung disease in patients with advanced cystic fibrosis homozygous for the F508del mutation

    P037 Elexacaftor/tezacaftor/ivacaftor improve lung disease in patients with advanced cystic fibrosis homozygous for the F508del mutation by Carnovale, V., Iacotucci, P., Terlizzi, V., Colangelo, C., Medio, P., Ferrillo, L., De Gregorio, F., Francalanci, M., Taccetti, G., Buonaurio, S., d'Ippolito, M., Marsicovetere, G., D'Andria, M., Ferrara, N., Salvatore, D.

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: